TY - JOUR
T1 - Considerations for Imaging of Malignant Pleural Mesothelioma
T2 - A Consensus Statement from the International Mesothelioma Interest Group
AU - Katz, Sharyn I.
AU - Straus, Christopher M.
AU - Roshkovan, Leonid
AU - Blyth, Kevin G.
AU - Frauenfelder, Thomas
AU - Gill, Ritu R.
AU - Lalezari, Ferry
AU - Erasmus, Jeremy
AU - Nowak, Anna K.
AU - Gerbaudo, Victor H.
AU - Francis, Roslyn J.
AU - Armato, Samuel G.
N1 - Publisher Copyright:
© 2022
PY - 2023/3
Y1 - 2023/3
N2 - Malignant pleural mesothelioma (MPM) is an aggressive primary malignancy of the pleura that presents unique radiologic challenges with regard to accurate and reproducible assessment of disease extent at staging and follow-up imaging. By optimizing and harmonizing technical approaches to imaging MPM, the best quality imaging can be achieved for individual patient care, clinical trials, and imaging research. This consensus statement represents agreement on harmonized, standard practices for routine multimodality imaging of MPM, including radiography, computed tomography, 18F-2-deoxy-D-glucose positron emission tomography, and magnetic resonance imaging, by an international panel of experts in the field of pleural imaging assembled by the International Mesothelioma Interest Group. In addition, modality-specific technical considerations and future directions are discussed. A bulleted summary of all technical recommendations is provided.
AB - Malignant pleural mesothelioma (MPM) is an aggressive primary malignancy of the pleura that presents unique radiologic challenges with regard to accurate and reproducible assessment of disease extent at staging and follow-up imaging. By optimizing and harmonizing technical approaches to imaging MPM, the best quality imaging can be achieved for individual patient care, clinical trials, and imaging research. This consensus statement represents agreement on harmonized, standard practices for routine multimodality imaging of MPM, including radiography, computed tomography, 18F-2-deoxy-D-glucose positron emission tomography, and magnetic resonance imaging, by an international panel of experts in the field of pleural imaging assembled by the International Mesothelioma Interest Group. In addition, modality-specific technical considerations and future directions are discussed. A bulleted summary of all technical recommendations is provided.
KW - Computed tomography
KW - Guidelines
KW - Magnetic resonance imaging
KW - Malignant mesothelioma
KW - Positron emission tomography
KW - Radiography
UR - http://www.scopus.com/inward/record.url?scp=85146027286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146027286&partnerID=8YFLogxK
U2 - 10.1016/j.jtho.2022.11.018
DO - 10.1016/j.jtho.2022.11.018
M3 - Review article
C2 - 36549385
AN - SCOPUS:85146027286
SN - 1556-0864
VL - 18
SP - 278
EP - 298
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 3
ER -